Cargando…
Is Fasting Good When One Is at Risk of Liver Cancer?
SIMPLE SUMMARY: Intermittent fasting has the potential to beneficially act upon several pathways that are involved in hepato-cellular carcinoma pathogenesis. Especially among non-alcoholic steatohepatitis patients (NASH), intermittent fasting could effectively reduce the chance of progression to adv...
Autores principales: | Minciuna, Iulia, van Kleef, Laurens A., Stefanescu, Horia, Procopet, Bogdan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600146/ https://www.ncbi.nlm.nih.gov/pubmed/36291868 http://dx.doi.org/10.3390/cancers14205084 |
Ejemplares similares
-
Metabolomics: From liver chiromancy to personalized precision medicine in advanced chronic liver disease
por: Procopet, Bogdan, et al.
Publicado: (2018) -
Navigating through the Lipid Metabolism Maze: Diagnosis and Prognosis Metabolites of Hepatocellular Carcinoma versus Compensated Cirrhosis
por: Nenu, Iuliana, et al.
Publicado: (2022) -
Ultrasound or Sectional Imaging Techniques as Screening Tools for Hepatocellular Carcinoma: Fall Forward or Move Forward?
por: Sparchez, Zeno, et al.
Publicado: (2021) -
Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease
por: Nicoară-Farcău, Oana, et al.
Publicado: (2020) -
Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy
por: Procopet, Bogdan, et al.
Publicado: (2017)